HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yuesong Wang Selected Research
Yuesong Wang Research Topics
Disease
6
Neoplasms (Cancer)
01/2023 - 11/2003
2
Porphyrias (Porphyria)
04/2008 - 04/2008
1
Esophageal Squamous Cell Carcinoma
03/2024
1
Esophageal Neoplasms (Esophageal Cancer)
10/2023
1
Myocardial Infarction
01/2023
1
Ventricular Remodeling
01/2023
1
Lung Neoplasms (Lung Cancer)
01/2021
1
Opium Dependence
01/2021
1
Marijuana Use
01/2020
1
Acute Intermittent Porphyria (Porphyria, Acute)
04/2008
Drug/Important Bio-Agent (IBA)
2
Biomarkers (Surrogate Marker)
IBA
03/2024 - 01/2021
2
ORALIT (ORS)
IBA
03/2024 - 01/2021
2
Heme (Haem)
IBA
04/2008 - 04/2008
2
Enzymes
IBA
04/2008 - 04/2008
1
Styrene (Styrol)
IBA
03/2024
1
propylene oxide
IBA
03/2024
1
1,3-butadiene (divinyl)
IBA
03/2024
1
N'-nitrosoanatabine
IBA
03/2024
1
Acrolein (Aqualin)
IBA
03/2024
1
Acrylonitrile
IBA
03/2024
1
Xylenes (Xylene)
IBA
03/2024
1
Nitrosamines
IBA
10/2023
1
Volatile Organic Compounds
IBA
10/2023
1
Carcinogens
IBA
10/2023
1
Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)
IBA
10/2023
1
Peptides (Polypeptides)
IBA
01/2023
1
Lipids
IBA
01/2023
1
IR1061
IBA
01/2023
1
Liposomes (Liposome)
IBA
01/2023
1
sacubitril
IBA
01/2023
1
pro-brain natriuretic peptide (1-76)
IBA
01/2023
1
sacubitril and valsartan sodium hydrate drug combination
IBA
01/2023
1
Valsartan (Vals)
FDA Link
01/2023
1
Irbesartan
FDA Link
Generic
01/2023
1
Homocysteine
IBA
01/2023
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
01/2023
1
Cystatin C
IBA
01/2023
1
Nitroreductases
IBA
02/2021
1
N-acetyl-S-(2-carbamoylethyl)-L-cysteine
IBA
01/2021
1
4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butan- 1- ol
IBA
01/2021
1
Nicotine
FDA Link
01/2021
1
Tobacco Smoke Pollution (Passive Smoking)
IBA
01/2020
1
Creatinine
IBA
01/2020
1
Indicators and Reagents (Reagents)
IBA
11/2003
1
DNA (Deoxyribonucleic Acid)
IBA
11/2003
Therapy/Procedure
2
Photothermal Therapy
11/2022 - 05/2022
1
Therapeutics
01/2023
1
Percutaneous Coronary Intervention
01/2023
1
Personal Protective Equipment
01/2023
1
Aftercare (After-Treatment)
01/2023